Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised 10x Genomics, Inc in connection with the acquisition of Spatial Transcriptomics
Mandate

Vinge has advised 10x Genomics, Inc in connection with the acquisition of Spatial Transcriptomics

December 11, 2018 M&A

Spatial Transcriptomics is active within the field of spatial genomics.

 

10x Genomics will continue to operate Spatial Transcriptomics out of their existing offices in Stockholm, with plans to grow their presence in Sweden.

Vinge’s team consisted of, among others, partners Christina Kokko and Kristina Ekberg as well as associates Anna Thoms, Klara Secher, Sophia Holm, Lova Unge, Stina Bengtsson and Frida Ställborn.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026